Articles tagged ‘’

Cardiac rhythm management expert Professor John Morgan, Consultant Cardiologist, Southampton University Hospitals NHS Trust, spoke to Arrhythmia Watch on the benefits of remote monitoring technology in patients with pacemakers and ICDs. He assesses the monitoring system’s benefits for clinical efficiency and economy. The UK is in a leading position Europe-wide in remote monitoring technology use.

Chronic heart failure (CHF) is a complex and lethal clinical syndrome accounting for an increasing number of Australian hospital admissions and more than 2,700 deaths in Australia in 2008, according to a recent update to the National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of chronic heart failure in Australia.¹

The first European guidelines specifically focused on managing dyslipidemias have been developed by researchers from the European Atherosclerosis Society (EAS) and European Society of Cardiology (ESC).^1,2 In particular the guidelines highlight how statin treatment reduces the risk of stroke in elderly patients.

Despite recent advances in the treatment of heart rhythm disturbances, mortality and morbidity rates associated with atrial fibrillation (AF) remain “unacceptably high”, according to a new report presented recently at the European Heart Rhythm Association (EHRA) EUROPACE 2011 congress in Madrid.

An extensive review on when to use tilt tables when testing patients for syncope has been published online by the European Society of Cardiology (ESC) Council for Cardiology Practice.¹

Despite new standards, guidelines, and educational efforts, acute pain after surgery continues to be undertreated worldwide, according to a study¹ published recently as part of The Lancet’s series on pain.

Defibrillators are to be donated to 24 UK schools as part of the Hand On Heart campaign – a collaboration between an online supplier of the devices and three firms linked to the industry.

A new study published in the journal Clinical Cardiology¹ reveals that in men with chronic heart failure, cardiac resynchronisation therapy (CRT) improves patients’ libido, erectile dysfunction, and sexual performance. Royal Brompton Hospital cardiologists comment on the paper to Arrhythmia Watch.

The precise populations of patients with chronic heart failure (HF) who could benefit from telemonitoring have been defined by two trials presented recently at the European Society of Cardiology’s (ESC) Heart Failure Congress 2011.

The EHRA-Europace and Cardiostim congresses on electrophysiology and the treatment of arrhythmias have agreed to consolidate their programmes under a common scientific committee, aiming to avoid fragmentation and provide a scientific continuum from one event to the next.